ProsTAV, a novel blood-based test for biopsy decision management in significant prostate cancer.
Saved in:
| Title: | ProsTAV, a novel blood-based test for biopsy decision management in significant prostate cancer. |
|---|---|
| Authors: | Gómez Gómez E; Department of Urology, Hospital Universitario Reina Sofía, Universidad de Córdoba, Investigación Biomédica de Córdoba, Córdoba, Spain., Cano Castiñeira R; Department of Urology, Hospital Infanta Margarita, Córdoba, Spain., Burgos J; Department of Urology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria, Madrid, Spain., Rodríguez Antolín A; Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain., Miles BJ; Urologic Oncology, Houston Methodist Hospital, Houston, Texas, USA., Martínez Salamanca JI; LYX Instituto de Urology, Madrid, Spain., Bianco F; Urological Research Network, Miami Lakes, Florida, USA., Fernández L; Life Length SL, Madrid, Spain., Calmarza I; Life Length SL, Madrid, Spain., Pastor J; Butler Scientifics, Barcelona, Spain., Butler RG; Butler Scientifics, Barcelona, Spain., de Pedro N; Life Length SL, Madrid, Spain. |
| Source: | The Prostate [Prostate] 2023 Oct; Vol. 83 (14), pp. 1323-1331. Date of Electronic Publication: 2023 Jul 06. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0045 |
|---|---|
| DOI: | 10.1002/pros.24594 |
